Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Estimating the size of COVID-19 epidemic outbreak

Chakrit Pongkitivanichkul, Daris Samart, Takol Tangphati, Phanit Koomhin, Pimchanok Pimton, Punsiri Dam-O, Apirak Payaka, Phongpichit Channuie
doi: https://doi.org/10.1101/2020.03.28.20044339
Chakrit Pongkitivanichkul
1Department of Physics, Faculty of Science, Khon Kaen University, Khon Kaen, 40002, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daris Samart
1Department of Physics, Faculty of Science, Khon Kaen University, Khon Kaen, 40002, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takol Tangphati
2Department of Physics, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phanit Koomhin
3School of Medicine, Walailak University, Nakhon Si Thammarat, 80160
4Research Group in Applied, Computational and Theoretical Science (ACTS), Walailak University, Nakhon Si Thammarat, 80160, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pimchanok Pimton
4Research Group in Applied, Computational and Theoretical Science (ACTS), Walailak University, Nakhon Si Thammarat, 80160, Thailand
5School of Science, Walailak University, Nakhon Si Thammarat, 80160, Thailand
6Plasmas and Electromagnetic Wave Science (PEwave) Center of Excellence, Walailak University, Nakhon Si Thammarat, 80160, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Punsiri Dam-O
4Research Group in Applied, Computational and Theoretical Science (ACTS), Walailak University, Nakhon Si Thammarat, 80160, Thailand
5School of Science, Walailak University, Nakhon Si Thammarat, 80160, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Apirak Payaka
4Research Group in Applied, Computational and Theoretical Science (ACTS), Walailak University, Nakhon Si Thammarat, 80160, Thailand
5School of Science, Walailak University, Nakhon Si Thammarat, 80160, Thailand
7College of Graduate Studies, Walailak University, Nakhon Si Thammarat, 80160, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phongpichit Channuie
4Research Group in Applied, Computational and Theoretical Science (ACTS), Walailak University, Nakhon Si Thammarat, 80160, Thailand
5School of Science, Walailak University, Nakhon Si Thammarat, 80160, Thailand
7College of Graduate Studies, Walailak University, Nakhon Si Thammarat, 80160, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: phongpichit.ch@mail.wu.ac.th
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

In this work, we analyze the epidemic data of cumulative infected cases collected from many countries as reported by WHO starting from January 21st 2020 and up till March 21st 2020. Our inspection is motivated by the renormalization group (RG) framework. Here we propose the RG-inspired logistic function of the form Embedded Image as an epidemic strength function with n being asymmetry in the modified logistic function. We perform the non-linear least-squares analysis with data from various countries. The uncertainty for model parameters is computed using the squared root of the corresponding diagonal components of the covariance matrix. We carefully divide countries under consideration into 2 categories based on the estimation of the inflection point: the maturing phase and the growth-dominated phase. We observe that long-term estimations of cumulative infected cases of countries in the maturing phase for both n = 1 and n ≠ 1 are close to each other. We find from the value of root mean squared error (RMSE) that the RG-inspired logistic model with n ≠ 1 is slightly preferable in this category. We also argue that n determines the characteristic of the epidemic at an early stage. However, in the second category, the estimated asymptotic number of cumulative infected cases contain rather large uncertainty. Therefore, in the growth-dominated phase, we focus on using n = 1 for countries in this phase. Some of them are in an early stage of an epidemic with an insufficient amount of data leading to a large uncertainty on parameter fits. In terms of the accuracy of the size estimation, the results do strongly depend on limitations on data collection and the epidemic phase for each country.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The authors have declared no competing interest.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 31, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Estimating the size of COVID-19 epidemic outbreak
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Estimating the size of COVID-19 epidemic outbreak
Chakrit Pongkitivanichkul, Daris Samart, Takol Tangphati, Phanit Koomhin, Pimchanok Pimton, Punsiri Dam-O, Apirak Payaka, Phongpichit Channuie
medRxiv 2020.03.28.20044339; doi: https://doi.org/10.1101/2020.03.28.20044339
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Estimating the size of COVID-19 epidemic outbreak
Chakrit Pongkitivanichkul, Daris Samart, Takol Tangphati, Phanit Koomhin, Pimchanok Pimton, Punsiri Dam-O, Apirak Payaka, Phongpichit Channuie
medRxiv 2020.03.28.20044339; doi: https://doi.org/10.1101/2020.03.28.20044339

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1101)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9782)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2318)
  • Geriatric Medicine (223)
  • Health Economics (463)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (507)
  • Infectious Diseases (except HIV/AIDS) (11656)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (240)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2148)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (366)
  • Orthopedics (129)
  • Otolaryngology (220)
  • Pain Medicine (148)
  • Palliative Medicine (50)
  • Pathology (313)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2188)
  • Public and Global Health (4673)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)